Holland Compared
hollandcompard_summer2015_LR
hollandcompard_summer2015_LR
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Life Sciences and Health<br />
Sector<br />
Helping to advance health worldwide<br />
• The Netherlands ranks 4th worldwide in patent applications for<br />
medical technology and 9th in patent applications for<br />
biotechnology..<br />
• With approximately 375 innovative life sciences companies<br />
clustered within a 120 mile radius, <strong>Holland</strong> is the most<br />
geographically concentrated region in the world when it comes to<br />
creating economic and social value in Life Sciences and Health.<br />
• Expertise in healthcare infrastructure is characterised by a<br />
turn-key plus approach: Dutch companies are able to cover all<br />
aspects from hospital design & engineering, financing, waste<br />
management, medical equipment etc. while paying special<br />
attention paid to energy efficiency and ‘healing environments’.<br />
• In 2011, Brainport Eindhoven’s Brainport region was named the<br />
world’s most intelligent ICT and health cluster.<br />
• The excellent medical research infrastructure is strongly focused<br />
on translational research in the different medical fields such<br />
oncology, cardiovascular, immunology and neuroscience.<br />
• The Netherlands is a global market leader in mobile health care,<br />
which enables the Dutch to contribute to rural health care in<br />
developing countries around the globe.<br />
• The industry annually exports around 37 billion euros in total of<br />
which 25 billion euros is pharmaceutical and the rest medical<br />
technology and medical and laboratory instruments.<br />
• The sector invests over 2 billion euros in R&D in the Netherlands<br />
each year and is becoming a globally recognized stronghold of<br />
open innovation. It already accounts for 2.5% of GDP.<br />
• Philips is the world leader in medical imaging and patient<br />
monitoring; DSM is a biomaterials leader.<br />
• The Dutch public-private partnership model, such as the<br />
Netherlands Genomics Initiative (NGI) and the three top institutes<br />
(TI Pharma, CTMM and BMM), have set an international standard.<br />
TOP SECTORS IN FOCUS 61